A comprehensive study of phenylalanine hydroxylase gene mutations in the Iranian phenylketonuria patients.
Iranian population
Mutation analysis
Phenyalanine hydroxylase
Phenylketonuria
Journal
European journal of medical genetics
ISSN: 1878-0849
Titre abrégé: Eur J Med Genet
Pays: Netherlands
ID NLM: 101247089
Informations de publication
Date de publication:
Sep 2019
Sep 2019
Historique:
received:
23
07
2018
revised:
09
10
2018
accepted:
24
10
2018
pubmed:
6
11
2018
medline:
21
1
2020
entrez:
4
11
2018
Statut:
ppublish
Résumé
Phenylketonuria (PKU) is a metabolic disorder caused by mutations in the phenylalanine hydroxylase (PAH) gene. After thalassemia, PKU is considered as the most common autosomal recessive diseases in the Iranian population. Therefore, an efficient diagnostic strategy is required to identify disease-causing mutations in this population. Following our first report in 2003, here we presented a comprehensive study on the mutation spectrum of the PAH gene in the Iranian population. This study was performed on 280 unrelated chromosomes from 140 Iranian patients with classic PKU. All 13 exons as well as exon-intron boundaries of the PAH gene were analyzed by direct DNA sequencing. Thirty four different mutations were identified by a mutation detection rate of 100%. IVS10-11G > A, p.P281L, R261Q, p.F39del and IVS11+1G > C were the most prevalent mutations with frequencies of 26.07%, 19.3%, 12.86%, 6.07 and 3.93%, respectively. All other mutations represented a relative frequency less than 3.5%. The data from this study provided a comprehensive spectrum of the PAH gene mutations which can facilitate carrier detection and prenatal diagnosis of PKU disease in the Iranian population.
Identifiants
pubmed: 30389586
pii: S1769-7212(18)30562-7
doi: 10.1016/j.ejmg.2018.10.011
pii:
doi:
Substances chimiques
Phenylalanine Hydroxylase
EC 1.14.16.1
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
103559Informations de copyright
Published by Elsevier Masson SAS.